Varenicline (CP 526555) 是一种有效的 α4β2 烟碱乙酰胆碱受体 (nAChR) 部分激动剂，EC50 值为 2.3 μM。
Varenicline is a partial agonist/antagonist of α4β2 nicotinic acetylcholine receptor [1].
Varenicline is a manufactured tartrate salt, it is a partial agonist of α4β2 nAChRs. The affinity(0.15 nM) of varenicline with α4β2 nAChRs is much more higher than with other nAChR subtypes. Through the binding, varenicline prevents nicotine from occupying the receptors and subsequently inhibit nicotine-induced dopaminergic activation. So varenicline is used for smoking cessation. In healthy adult smokers, varenicline does not undergo significant hepatic metabolism and the clearance(>90%) is predominantly renal. It is shown that the amphetamine administration may have decrease the efficacy of varenicline [1].
参考文献:
[1] Garrison GD, Dugan SE. Varenicline: a first-line treatment option for smoking cessation. Clin Ther. 2009 Mar;31(3):463-91.
动态评分
0.0